CD40 ligation inhibits trichilemmoma cell proliferation and induces IL-6 production

Journal of Dermatological Science

Volumn 22, Issue 2, 2000, Pages 125-131

  Amo, Yasuyuki ^a   Ohta, Yukinori ^a   Katsuoka, Kensei ^a   Tamauchi, Hidekazu ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD40; Interleukin 6; Trichilemmoma cell

Indexed keywords

CD40 ANTIGEN; COMPLEMENTARY RNA; CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; TRICHILEMMOMA; TUMOR CELL;

ANTIGENS, CD40; CELL DIVISION; HUMANS; INTERLEUKIN-6; LIGANDS; NEOPLASMS, BASAL CELL; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033991806     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00057-2     Document Type: Article

References (21)

1. Clark E.A., Ledbetter J.A. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Proc Natl Acad Sci USA. 83:1986;4494-4498.
2. Ledbetter J.A., Shu G., Gallagher M., Clark E.A. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen Bp50 (CDw40). J Immunol. 138:1987;788-794.
3. Armitage R.J., Fanslow W.C., Strockbine L., Sato T.A., Clifford K.N., Macduff B.M., Anderson D.M., Gimpel S.D., Davis-Smith T., Maliszewski C.R., Clark E.A., Smith C.A., Grabstein K.H., Cosman D., Spriggs M.K. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:1992;80-82.
4. Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J.P., Kooten C., Liu F.R., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu Rev Immnol. 12:1994;881-922.
5. Snapper C.M., Zelazowski P., Rosas F.R., Kehry M.R., Tian M., Baltimore D., Sha W.C. B cells from p50/NF-(B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol. 156:1996;183-191.
6. Hess S., Rensing-Ehl A., Schwabe R., Bufler P., Engelmann H. CD40 function in non-hematopoietic cells. J Immunol. 155:1995;4588-4595.
7. Péguet-Navarro J., Dalbiez-Gauthier C., Moulon C., Berthier O., Réano A., Gaucherand M., Banchereau J., Rousset F., Schmitt D. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol. 158:1997;144-152.
8. Clark E.A., Shu G. Association between IL-6 and CD40 signaling. J Immunol. 145:1990;1400-1406.
9. Gillitzer R., Berger R., Mielke V., Müller C., Wolff K., Stingl G. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8m RNA in situ. J Invest Dermatol. 97:1991;73-79.
10. Gaspari A.A., Sempowski G.D., Chess P., Gish J., Phipps R.P. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol. 26:1996;1371-1377.
11. Krueger J., Ray A., Tamm I., Sehgal P.B. Expression and function of Interleukin-6 in epithelial cells. J Cell Biochem. 45:1991;327-334.
12. Nishioka K., Funato T., Sato Y., Ohta Y., Eto H., Katayama I., Nishiyama S. Production of interleukin-1 alpha by a trichilemmoma cell line. J Dermatol (Tokyo). 17:1990;205-210.
13. Kanzaki T., Eto H., Umezawa A., Maeda T., Iwase H., Ito M. Morphological, biological and biochemical characteristics of a benign human trichilemmoma cell line in vivo and in vitro. Cancer Res. 41:1981;2468-2475.
14. Ohta Y., Kijima H., Kashani-Sabet M., Scanlon K.J. Suppression of the malignanmt phenotype of melanoma cells by anti-oncogene ribozymes. J Invest Dermatol. 106:1996;275-280.
15. Elipoulos A.G., Dawson C.W., Mosialos G., Floettmann J.E., Rowe M., Armitage R.J., Dawson J., Zapata J.M., Kerr D.J., Wakelam M.J.O., Reed J.C., Kieff E., Young L.S. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene. 13:1996;2243-2254.
16. Thomas W.D., Smith M.J., Si Z., Hersey P. Expression of the co-stimulatory molecule CD40 on melanoma cells. Int J Cancer. 68:1996;795-801.
17. Ohta Y., Nishiyama S., Nishioka K. In situ expression of IL-6 in psoriatic epidermis during treatment. J Dermatol (Tokyo). 21:1994;301-307.
18. Neuner P., Urbanski A., Trautinger F., Möller A., Kirnbauer R., Kapp A., Schöpf E., Schwarz T., Luger T.A. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol. 97:1991;27-33.
19. Denfeld R.W., Hollenbaugh D., Fehrenbach A., Weiss J.M., Leoprechting A., Mai B., Voith U., Schöpf E., Aruffo A., Simon J.C. CD40 is functionally expressed on human keratinocytes. Eur J Immunol. 26:1996;2329-2334.
20. Ohta Y., Katayama I., Funao T., Yokozeki H., Nishiyama S., Hirano T., Kishimoto T., Nishioka K. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis. Arch Dermatol Res. 283:1991;351-356.
21. Viac J., Schmitt D., Claudy A. CD40 expression in epidermal tumors. Anticancer Res. 17:1997;562-572.